NEW YORK – Novacyt said on Monday that it has partnered with German company BioType Diagnostic to manufacture its COVID-19 test. Under the agreement, BioType, based in Dresden, has delivered the first batches of products for final assembly to Primerdesign, Novacyt's UK-based molecular diagnostics division.